Literature DB >> 22346544

Seroprevalence of cytomegalovirus, Toxoplasma gondii, syphilis, and hepatitis B and C virus infections in a regional population seropositive for HIV infection.

D G Johns1, M J Gill.   

Abstract

OBJECTIVE: To determine the prevalence of exposure to cytomegalovirus (CMV), Toxoplasma gondii, syphilis, hepatitis B virus (HBV) and hepatitis C virus (HCV) in a large, well characterized, regional population presenting for human immunodeficency virus (HIV) care.
DESIGN: Demographic and serological data compiled prospectively in a relational database used for routine patient care. Results were analyzed for statistically significant trends within demographic subpopulations known to be at risk of such infections. PATIENTS AND
SETTING: A total of 1274 persons with documented HIV infection in southern Alberta have sought medical care since 1985. Serological status to CMV, T gondii, syphilis, HBV and HCV infections were routinely requested as part of the initial assessment. All patients with serological results available were included in the analysis.
RESULTS: CMV infection was found in 84.1% of patients. A lower prevalence of CMV infection in those under 30 yeasr old (P<0.001), intravenous drug users (IVDUs) (P=0.001) and in patients with transfusion-acquired HIV (P<0.001) was seen. T gondii seropositivity was found in 10.6% of patients, with an increased risk of seropositivity in those born outside of Canada (P<0.001). Syphilis seropositivity was present in 5.1% of patients, with a higher prevalence in gay males (P=0.1). HBV carrier status was noted in 8.0% of patients, with males having an increased risk (P=0.025). Since 1990, there has been a 17.6% prevalence of HCV, predominantly in IVDUs (P<0.001).
CONCLUSION: Seroprevalence to common pathogens in HIV disease varies significantly among subpopulations, necessitating individual testing.

Entities:  

Keywords:  Education; Epidemiology; Opportunistic infections; Prevention; Risk factors

Year:  1998        PMID: 22346544      PMCID: PMC3250888          DOI: 10.1155/1998/380687

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  19 in total

1.  1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-06-27

2.  Hepatitis C virus infection in a human immunodeficiency virus-positive cohort in Hawaii.

Authors:  R L Vogt; S Richmond-Crum; A Diwan
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

3.  Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases.

Authors:  T C Quinn; D Glasser; R O Cannon; D L Matuszak; R W Dunning; R L Kline; C H Campbell; E Israel; A S Fauci; E W Hook
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

Review 4.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

Review 5.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

6.  Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents.

Authors:  S L Rosenthal; L R Stanberry; F M Biro; M Slaoui; M Francotte; M Koutsoukos; M Hayes; D I Bernstein
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

Review 7.  HIV and syphilis seroprevalence among clients with sexually transmitted diseases attending a walk-in clinic at Cook County Hospital.

Authors:  D A Ansell; T C Hu; M Straus; M Cohen; R Sherer
Journal:  Sex Transm Dis       Date:  1994 Mar-Apr       Impact factor: 2.830

8.  Human immunodeficiency virus and hepatitis B virus seroprevalence in an urban trauma population.

Authors:  E P Sloan; B A McGill; R Zalenski; P Tsui; E H Chen; J Duda; M Morris; R Sherer; J Barrett
Journal:  J Trauma       Date:  1995-05

9.  Antibody to a hepatitis C virus related protein among patients at high risk for hepatitis B.

Authors:  A Widell; B G Hansson; E Berntorp; T Moestrup; H P Johansson; H Hansson; E Nordenfelt
Journal:  Scand J Infect Dis       Date:  1991

10.  Use of a clinical laboratory database to estimate Toxoplasma seroprevalence among human immunodeficiency virus-infected patients. Overcoming bias in secondary analysis of clinical records.

Authors:  W C Mathews; S C Fullerton
Journal:  Arch Pathol Lab Med       Date:  1994-08       Impact factor: 5.534

View more
  2 in total

1.  Prevention of perinatal transmission of HIV infection.

Authors:  J L Robinson; B E Lee
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

Review 2.  Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis.

Authors:  Ashly E Jordan; David C Perlman; Joshua Neurer; Daniel J Smith; Don C Des Jarlais; Holly Hagan
Journal:  Int J STD AIDS       Date:  2016-07-10       Impact factor: 1.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.